Daily Intelligence Brief
Docket Roundup: Five MDLs Concentrate the Day’s Intake
Filing volume tightened around five repeat-player dockets, with concentrated firm channels rather than diffuse intake driving the day’s movement. Zantac Products Liability Litigation (2924) led with 19 filings, all from Keller Postman LLC, while Uber Technologies, Inc., Passenger Sexual Assault Litigation (3084) followed with 17 cases through Chaffin Luhana LLP. Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) logged 10 filings, with Peiffer Wolf filing six and Douglas & London three, while Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873) added six as Krentsel & Guzman LLP filed three and Environmental Litigation Group PC filed one. Glucagon-like Peptide-1 Receptor Agonists Products Liability (Gastroparesis) Litigation (3094) rounded out the group with five matters led by Levin Papantonio’s three and Morgan & Morgan PA’s one, reinforcing how a limited roster of firms is setting the docket’s immediate pace. See the full filing feed and firm-level breakdowns here.
California’s Youth-Feed Law Stays in Force During Appeal
A federal judge on Aug. 25 left California’s Protecting Our Kids from Social Media Addiction Act enforceable while platform defendants pursue their appeal, preserving parental-consent requirements for personalized feeds. The court concluded that the companies had not shown their predictive recommendation systems communicate an expressive message and declined to treat projected compliance costs as irreparable harm. The refusal to pause enforcement does not resolve the constitutional appeal, but it puts live product-control obligations alongside the evidence disputes confronting the industry. In Social Media Adolescent Addiction/Personal Injury Products Liability Litigation (3047), the ruling can focus discovery on how defendants identify minor users, obtain consent, configure recommendations and limit notifications.
Pennsylvania Sets Sept. 2 PFAS Biosolids Comment Deadline
Pennsylvania’s proposed biosolids permits face a Sept. 2 public-comment deadline, forcing wastewater facilities and affected stakeholders to address conditions aimed at reducing PFOA and PFOS releases onto farm fields. The draft PAG-07, PAG-08 and PAG-09 permit terms would require quarterly PFAS testing and require facilities exceeding proposed thresholds to develop plans for reducing PFAS entering their treatment systems. The proposal is not a statewide ban and the permit terms are not final, but the proceeding will establish a defined record on source control and PFAS migration through wastewater residuals. That regulatory record can sharpen environmental-pathway and cleanup-allocation disputes in Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873).
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.